scholarly journals Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study

Diabetes Care ◽  
2019 ◽  
Vol 42 (6) ◽  
pp. 1027-1033 ◽  
Author(s):  
Adem Y. Dawed ◽  
Kaixin Zhou ◽  
Nienke van Leeuwen ◽  
Anubha Mahajan ◽  
Neil Robertson ◽  
...  
2018 ◽  
Author(s):  
Adem Y Dawed ◽  
Kaixin Zhou ◽  
Nienke van Leeuwen ◽  
Anubha Mahajan ◽  
Neil Robertson ◽  
...  

AbstractObjectives20-30% of patients with metformin treated type 2 diabetes experience gastrointestinal side effects leading to premature discontinuation in 5-10% of the cases. Gastrointestinal intolerance may reflect localised high concentrations of metformin in the gut. We hypothesized that reduced transport of metformin into the circulation via the plasma membrane monoamine transporter (PMAT) and organic cation transporter 1 (OCT1) could increase the risk of severe GI side effects.Research Design and MethodsThe study included 286 severe metformin intolerant and 1128 tolerant individuals from the IMI DIRECT consortium. We assessed the association of patient characteristics, concomitant medication and the burden of mutations in the SLC29A4 and SLC22A1, genes that encode PMAT and OCT1, respectively, on odds of metformin intolerance using a logistic regression model.ResultsWomen (p < 0.001) and older people (p < 0.001) were more likely to develop metformin intolerance. Concomitant use of metformin transporter inhibiting drugs increased the odds of intolerance by more than 70% (OR = 1.72 [1.26-2.32], p < 0.001). In a logistic regression model adjusted for age, sex, weight and population substructure, the G allele at rs3889348 (SLC29A4) was associated with GI intolerance (OR = 1.34[1.09-1.65], p = 0.005). rs3889348 is the top cis-eQTL for SLC29A4 in gut tissue where carriers of the G allele had reduced expression. Homozygous carriers of the G allele treated with metformin transporter inhibiting drugs had over three times higher odds of intolerance compared to carriers of no G allele and not treated with inhibiting drugs (OR = 3.23 [1.71-6.39], p < 0.001). Using a genetic risk score (GRS) derived from SLC29A4 (rs3889348) and previously reported SLC22A1 variants (M420del, R61C, G401S), the odds of intolerance was more than twice in individuals who carry three or more risk alleles compared with those carrying none (OR = 2.15 [1.20-4.12], p = 0.01).ConclusionsThese results suggest that intestinal metformin transporters and concomitant medications play an important role in gastrointestinal side effects of metformin.


2015 ◽  
Vol 33 (4) ◽  
pp. 511-514 ◽  
Author(s):  
T. Dujic ◽  
A. Causevic ◽  
T. Bego ◽  
M. Malenica ◽  
Z. Velija-Asimi ◽  
...  

Medicine ◽  
2018 ◽  
Vol 97 (27) ◽  
pp. e11349 ◽  
Author(s):  
Edith Pascale Mofo Mato ◽  
Magellan Guewo-Fokeng ◽  
M. Faadiel Essop ◽  
Peter Mark Oroma Owira

Diabetes ◽  
2014 ◽  
Vol 64 (5) ◽  
pp. 1786-1793 ◽  
Author(s):  
Tanja Dujic ◽  
Kaixin Zhou ◽  
Louise A. Donnelly ◽  
Roger Tavendale ◽  
Colin N.A. Palmer ◽  
...  

2021 ◽  
Vol 22 (24) ◽  
pp. 13420
Author(s):  
Nikki J. Clauss ◽  
Wouter Koek ◽  
Lynette C. Daws

A lack of effective treatment and sex-based disparities in psychostimulant addiction and overdose warrant further investigation into mechanisms underlying the abuse-related effects of amphetamine-like stimulants. Uptake-2 transporters such as organic cation transporter 3 (OCT3) and plasma membrane monoamine transporter (PMAT), lesser studied potential targets for the actions of stimulant drugs, are known to play a role in monoaminergic neurotransmission. Our goal was to examine the roles of OCT3 and PMAT in mediating amphetamine (1 mg/kg)-induced conditioned place preference (CPP) and sensitization to its locomotor stimulant effects, in males and females, using pharmacological, decynium-22 (D22; 0.1 mg/kg, a blocker of OCT3 and PMAT) and genetic (constitutive OCT3 and PMAT knockout (−/−) mice) approaches. Our results show that OCT3 is necessary for the development of CPP to amphetamine in males, whereas in females, PMAT is necessary for the ability of D22 to prevent the development of CPP to amphetamine. Both OCT3 and PMAT appear to be important for development of sensitization to the locomotor stimulant effect of amphetamine in females, and PMAT in males. Taken together, these findings support an important, sex-dependent role of OCT3 and PMAT in the rewarding and locomotor stimulant effects of amphetamine.


2012 ◽  
Vol 40 (6) ◽  
pp. 1138-1143 ◽  
Author(s):  
Shiro Itagaki ◽  
Vadivel Ganapathy ◽  
Horace T. B. Ho ◽  
Mingyan Zhou ◽  
Ellappan Babu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document